Shares of Dr Reddy’s Laboratories fell 4 percent on Monday morning as investors reacted to observations being issued to the company by US FDA.
The stock touched an intraday high of Rs 2,704.70 and an intraday low of Rs 2,659.95.
The company on Friday told the exchanges that its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad had been inspected by the US FDA.
The stock touched an intraday high of Rs 2,704.70 and an intraday low of Rs 2,659.95.
The company on Friday told the exchanges that its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad had been inspected by the US FDA.
No comments:
Post a Comment